19075-53-7

Basic information

• Product Name: 6-bromo-benzo[b]thiophene-3-carbaldehyde
• Synonyms: 6-bromo-benzo[b]thiophene-3-carbaldehyde
• CAS NO: 19075-53-7
• Molecular Weight: 241.108
• Mol File: 19075-53-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 6-bromo-benzo[b]thiophene-3-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-bromo-benzo[b]thiophene-3-carbaldehyde(19075-53-7)
• EPA Substance Registry System: 6-bromo-benzo[b]thiophene-3-carbaldehyde(19075-53-7)

Safety Data

• Hazardous Substances Data: 19075-53-7(Hazardous Substances Data)

Upstream product

• 7342-82-7 3-Bromothianaphthene 
• 95-15-8 Benzo[b]thiophene 
• 5381-20-4 benzothiophene-3-carboxaldehyde 
• 17347-32-9 6-bromobenzothiophene 
• 105191-64-8 6-Brombenzothiophen-2-carbonsaeure-ethylester 
• 1426082-37-2 3,6-dibromobenzo[b]thiophene 
• 68-12-2 N,N-dimethyl-formamide 
• 19075-58-2 6-bromo-1-benzothiophene-2-carboxylic acid 
• 57848-46-1 4-bromo-2-fluorobenzaldehyde 
• 19075-36-6 6-bromo-3-methylbenzothiophene 

Downstream Products

• 1426082-13-4 6-{2-[4-(2-dimethylamino-ethoxy)-phenyl]-5-pyridin-4-yl-3H-imidazol-4-yl}-benzo[b]thiophene-3-carbaldehyde 
• 1426082-14-5 (6-{2-[4-(2-dimethylamino-ethoxy)-phenyl]-5-pyridin-4-yl-3H-imidazol-4-yl}-benzo[b]thiophen-3-yl)-methanol 
• 1426082-15-6 1-(6-{2-[4-(2-dimethylamino-ethoxy)-phenyl]-5-pyridin-4-yl-3H-imidazol-4-yl}-benzo[b]thiophen-3-yl)-propan-1-ol 

Relevant articles and documents

PPAR (peroxisome proliferator-activated receptor) agonist and application thereof to treatment of senile dementia and other diseases

The invention relates to a compound, namely a gamma-subtype peroxisome proliferator-activated receptor (PPAR) agonist. In addition, the invention discloses a medicinal component and a preparation containing the compound and application of such the gamma-subtype PPAR agonist.

Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors

A small library of 3-[(4-hydroxycarbamoylphenyl)aminomethyl]benzothiophenes was prepared and assessed as a novel class of HDAC6 inhibitors, leading to the identification of three representatives as potent and selective HDAC6 inhibitors. Further tests with

Pharmaceutical compounds

This invention relates to compounds of formula (I) where R1 to R12, —W—V—, —X—Y—, m and n have the values defined in claim 1, their preparation and use as pharmaceuticals.